Ozempic-style drugs are now in trials for heart failure, addiction and even aging
The share of Ozempic-style drug trials aimed beyond diabetes and weight has roughly tripled in fifteen years, across fifteen disease areas.
The share of Ozempic-style drug trials aimed beyond diabetes and weight has roughly tripled in fifteen years, across fifteen disease areas.
The Suez Canal carries a little over half the cargo it did before the attacks, and the ships that left still round Africa.
In one week two teams moved AI to the lab bench: an 11,382-step DNA experiment, and a vault structure mapped with Claude.
Six weeks after dropping a novel over suspected AI, the Goncourt jury crowned Philippe Jaenada, who says he used AI three times.
Chrome stops running XSLT on November 17. WordPress, Yoast and other vendors are removing or replacing the stylesheet on their sitemaps.
METR got inside Anthropic’s data. Its verdict: progress has roughly doubled, mostly thanks to AI, and most of the evidence stays redacted.
The self-hosted interface lets models drive a desktop and a browser, lifts default limits and ships security fixes that are not yet described.
Starting November 9, new self-serve ChatGPT Ads campaigns lose bid caps and can use average cost targets. Running campaigns switch on January 1.
In an OpenAI test, GPT-6 Astra completed about 40% fewer rubric items on tasks framed as AI safety research than on matched ones.
OpenAI describes an agent pipeline that found and exploited 948 Linux kernel flaws and drafted a candidate patch for each one.